Adam L. Tomasi Ph.D.
Net Worth

Last updated:

What is Adam L. Tomasi Ph.D. net worth?

The estimated net worth of Dr. Adam L. Tomasi Ph.D. is at least $6,299,107 as of 31 Aug 2021. He owns shares worth $48,779 as insider, has earned $800,328 from insider trading and has received compensation worth at least $5,450,000 in Allakos Inc..

What is the salary of Adam L. Tomasi Ph.D.?

Dr. Adam L. Tomasi Ph.D. salary is $1,090,000 per year as Pres & Chief Operating Officer in Allakos Inc..

How old is Adam L. Tomasi Ph.D.?

Dr. Adam L. Tomasi Ph.D. is 55 years old, born in 1970.

What stocks does Adam L. Tomasi Ph.D. currently own?

As insider, Dr. Adam L. Tomasi Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Allakos Inc. (ALLK) Pres & Chief Operating Officer 148,220 $0.33 $48,779

What does Allakos Inc. do?

Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; a Phase II/III study for eosinophilic esophagitis; and a Phase II clinical study to atopic dermatitis and chronic spontaneous urticaria. It is also developing lirentelimab (AK002) for the treatment of mast cell gastrointestinal disease, chronic urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis; and AK006 to treat allergic and inflammatory diseases. The company was incorporated in 2012 and is headquartered in Redwood City, California.

ALLK logo
ALLK
Allakos Inc.
$0.33

Adam L. Tomasi Ph.D. insider trading

Allakos Inc.

Dr. Adam L. Tomasi Ph.D. has made 14 insider trades between 2020-2021, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 64,148 units of ALLK stock on 31 Aug 2021. As of 31 Aug 2021 he still owns at least 148,220 units of ALLK stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 64,148 $4.31 $276,670
Option
Stock Option (Right to buy) 64,148 $4.31 $276,670
Option
Stock Option (Right to buy) 20,000 $0.69 $13,760
Option
Common Stock 20,000 $0.69 $13,760
Sale
Common Stock 20,000 $0.69 $13,760
Sale
Common Stock 20,000 $0.69 $13,760
Option
Common Stock 20,000 $0.69 $13,760
Option
Stock Option (Right to buy) 20,000 $0.69 $13,760
Sale
Common Stock 2,487 $92.03 $228,879
Sale
Common Stock 642 $90.26 $57,947
Sale
Common Stock 20,000 $0.69 $13,760
Option
Common Stock 20,000 $0.69 $13,760
Option
Stock Option (Right to buy) 20,000 $0.69 $13,760
Sale
Common Stock 20,000 $0.69 $13,760
Option
Stock Option (Right to buy) 20,000 $0.69 $13,760
Option
Common Stock 20,000 $0.69 $13,760
Option
Stock Option (Right to buy) 20,000 $0.69 $13,760
Sale
Common Stock 20,000 $0.69 $13,760
Option
Common Stock 20,000 $0.69 $13,760
Option
Stock Option (Right to buy) 20,000 $0.69 $13,760
Sale
Common Stock 20,000 $0.69 $13,760
Option
Common Stock 20,000 $0.69 $13,760
Option
Common Stock 20,000 $0.69 $13,760
Sale
Common Stock 20,000 $0.69 $13,760
Option
Stock Option (Right to buy) 20,000 $0.69 $13,760
Option
Common Stock 20,000 $0.69 $13,760
Option
Stock Option (Right to buy) 20,000 $0.69 $13,760
Sale
Common Stock 20,000 $0.69 $13,760
Option
Common Stock 20,000 $0.69 $13,760
Option
Stock Option (Right to buy) 20,000 $0.69 $13,760
Sale
Common Stock 20,000 $0.69 $13,760
Option
Stock Option (Right to buy) 20,000 $0.69 $13,760
Option
Common Stock 20,000 N/A N/A
Sale
Common Stock 20,000 $0.69 $13,760
Option
Common Stock 20,000 N/A N/A
Sale
Common Stock 20,000 $0.69 $13,760
Option
Stock Option (Right to buy) 20,000 N/A N/A
Sale
Common Stock 3,189 $113.56 $362,143
Option
Stock Option (Right to buy) 5,416 N/A N/A
Option
Common Stock 5,416 N/A N/A

Allakos key executives

Allakos Inc. executives and other stock owners filed with the SEC: